![David Canner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Canner
Direktör/Styrelseledamot på
INHIBIKASE THERAPEUTICS, INC.
Förmögenhet: - $ per 2026-06-30
Profil
David Canner is currently an Independent Director at Inhibikase Therapeutics, Inc. since 2024.
Dr. Canner is also a Partner at Soleus Capital LLC since 2018.
Dr. Canner holds a doctorate from the Massachusetts Institute of Technology and an undergraduate degree from Princeton University.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
| 2026-06-26 | 0 ( -.--% ) | - $ | 2026-06-30 |
Aktiva positioner av David Canner
| Företag | Position | Start |
|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Direktör/Styrelseledamot | 2024-10-21 |
Soleus Capital LLC | Företagsledare/Principal | 2018-01-01 |
David Canners utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
16
Första gradens relationer
4
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Inhibikase Therapeutics, Inc.
 Inhibikase Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small-molecule kinase inhibitor therapeutics for neurological diseases | Health Technology |
Soleus Capital LLC |
